Chestnut (Sweet Chestnut, Castanea sativa)

Castanea sativa
Evidence Level
Limited
5 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

Sweet chestnuts are the edible nuts of Castanea trees, mainly the European Castanea sativa and related Asian and American species, eaten roasted or boiled or as chestnut flour. Unlike most tree nuts they are low in fat and high in carbohydrate: USDA lists 245 kcal, 2.2 g of fat and 53.0 g of carbohydrate per 100 g of roasted European chestnuts. They are not horse chestnuts, a different tree whose raw seeds are unsafe to eat. In a single-meal test in 14 healthy adults, bread made half with chestnut flour gave a smaller blood sugar rise than wheat bread, while insulin did not differ. Chestnut tannin extracts were tested in people only blended with quebracho: one blend improved bowel symptom scores against placebo in a maker-linked trial, and another did not shorten hospital stays. FDA does not count chestnut as a major food allergen, and its 2003 nut claim does not name chestnuts.

Studied Dose Chestnut flour: bread made with 50 percent chestnut flour in one meal with 50 g of carbohydrate. Quebracho and chestnut tannin blends: 480 mg a day for 56 to 60 days, or two 240 mg capsules a day for 14 days. No supplement dose is established.
Active Compound Edible chestnut kernels (Castanea sativa and other Castanea species), eaten roasted or boiled or milled into flour. Per 100 g of roasted European chestnuts, USDA lists 245 kcal, 53.0 g of carbohydrate (10.6 g of sugars), 5.1 g of fiber, 3.17 g of protein, 2.2 g of fat, 592 mg of potassium, 26 mg of vitamin C and 1.18 mg of manganese. Supplement extracts are hot-water extracts of chestnut (described as bark in one trial registry title) rich in ellagitannins, tested in people only as blends with quebracho wood tannins, such as Welltan® Complex (Quebracho and Chestnut Tannin Blend).

Benefits

Blood sugar response to bread made with chestnut flour

In a randomized crossover test in 14 healthy adults, bread made with 50 percent chestnut flour, eaten as a meal with 50 g of carbohydrate, gave a 27 percent smaller blood sugar rise over 3 hours than wheat bread, mostly at 2 to 2.5 hours. Total insulin response did not differ. This was a single-meal blood marker test, not a longer feeding trial.

Bowel symptom scores with a chestnut and quebracho tannin blend

In 156 adults with irritable bowel syndrome, 480 mg a day of a quebracho and chestnut tannin blend for 56 days ended with symptom scores about 98 points lower than placebo, whose scores rose. Stool form did not differ. The first author works for the maker, which provided the product, and chestnut was not tested on its own.

Time to hospital discharge with a quebracho and chestnut tannin blend

In 124 adults hospitalized with COVID-19, a quebracho and chestnut tannin blend with vitamin B12 for 14 days, added to standard care, did not shorten time to discharge, the primary outcome, or change mortality or ventilation compared with placebo. One blood cytokine, MIP-1 alpha, fell with the blend. The maker partly funded the trial.

Starch digestion and chestnut inner skin extract

In lab tests, an ethanol extract of chestnut astringent inner skin blocked alpha-amylase, an enzyme that digests starch, and in rats it blunted the blood sugar rise after starch. In people eating boiled rice, 300 and 600 mg of the extract reduced the blood sugar rise by 11 and 23 percent; the abstract gives no group size or control details.

Nutrient profile: high in carbohydrate and low in fat for a nut

Per 100 g of roasted European chestnuts, USDA lists 245 kcal, 53.0 g of carbohydrate, 5.1 g of fiber, 3.17 g of protein and 2.2 g of fat, compared with 654 kcal and 65.2 g of fat in English walnuts. Chestnuts also supply 592 mg of potassium, 26 mg of vitamin C and 1.18 mg of manganese per 100 g.

Mechanism of action

1

Fiber, resistant starch and polyphenols in chestnut flour

The bread trial authors propose that chestnut's fiber, resistant starch and polyphenols slow starch digestion. Their chestnut bread held about 480 mg of total polyphenols, including catechin, myricetin and gallic acid, against about 100 mg in wheat bread, and the blood sugar difference appeared mainly late, at 120 to 150 minutes.

2

Alpha-amylase inhibition by chestnut skin tannins

In laboratory tests, an extract of the astringent inner skin of chestnut strongly inhibited human pancreatic alpha-amylase, the enzyme that breaks starch into sugars, and in rats it slowed the rise in blood sugar and insulin after a starch load. Whether usual chestnut foods deliver enough of these compounds to act this way has not been tested.

3

Chestnut tannins and gut bacteria

Chestnut tannin extracts are rich in ellagitannins, which gut bacteria break down. In an uncontrolled 60 day pilot of a quebracho and chestnut blend, stool butyrate rose and propionate fell, while in a placebo-controlled hospital trial the blend did not shift the gut microbiome significantly over 14 days.

4

Sweet chestnut and horse chestnut are different plants

Sweet chestnuts come from Castanea trees. Horse chestnut is Aesculus hippocastanum, an unrelated tree whose seeds resemble sweet chestnuts but taste bitter; NCCIH states that its raw seeds, bark, flowers and leaves contain a toxic component and are unsafe by mouth. Research on horse chestnut seed extract does not apply to sweet chestnut.

Clinical trials

1
50 Percent Chestnut Flour Bread vs Wheat Bread: Single-Meal Blood Sugar Test
PubMed

Randomized crossover single-meal trial; isocaloric meals with 50 g of available carbohydrate as bread made with 50 percent chestnut flour and 50 percent wheat flour or as 100 percent wheat bread, after an overnight fast, with capillary glucose and insulin over 180 minutes; funding and registration not stated in the abstract, while a Monash University registry entry by the senior author (NCT06960967) lists glucose and insulin responses as primary outcomes (Houghton et al. 2026, Food Funct)

14 healthy adults.

The glucose incremental area under the curve was 27 percent lower after the chestnut flour bread (p = 0.0319), with glucose 16 percent lower at 120 minutes and 14 percent lower at 150 minutes. Total insulin exposure did not differ, and the insulin peak came about 24 minutes earlier. The chestnut bread held about 480 mg of polyphenols against about 100 mg in the wheat bread.

2
Chestnut and Quebracho Tannin Blend vs Placebo for 56 Days: Bowel Symptom Score
PubMed

Single-center randomized, double-blind, placebo-controlled parallel trial; two 240 mg capsules a day (480 mg) of Welltan® Complex (Quebracho and Chestnut Tannin Blend) from Silvateam for 56 days; primary outcome the IBS Severity Scoring System; ISRCTN registered; no external funding stated, product supplied free by the INBB consortium as sponsor and credited to Silvateam, which employs the first author (Molino et al. 2025, Nutrients)

156 adults aged 18 to 70 with irritable bowel syndrome by Rome IV criteria, 78 per group; 87 diarrhea-predominant, 20 constipation-predominant and 49 with both patterns.

At 56 days the symptom score averaged 148 on the blend and 247 on placebo (model difference 98 points, p < 0.001); the blend group started 25 points higher and fell, while placebo scores rose about 30 points. Quality of life scores favored the blend, though they differed sharply between groups at baseline. Bristol stool consistency did not differ by treatment, and no side effects were reported.

3
Quebracho and Chestnut Tannin Blend vs Placebo for 14 Days in Hospitalized Adults (null primary)
PubMed

Randomized, double-blind, placebo-controlled parallel trial added to standard care; Arbox Microbiota (Indunor S.A.), capsules with 240 mg of a quebracho and chestnut tannin extract blend and 0.72 micrograms of vitamin B12, two a day for 14 days; primary outcome time to hospital discharge within 28 days; registered NCT04403646; supported in part by Silvateam/Indunor SA and by NIH grants (Molino et al. 2022, J Funct Foods)

124 adults hospitalized in Buenos Aires with non-life-threatening COVID-19, with 53 healthy adults as a baseline comparison group.

Time to discharge, 28-day mortality and invasive ventilation did not differ from placebo, and the gut microbiome did not shift significantly after 14 days. MIP-1 alpha, one of the cytokines measured, fell with the blend (p = 0.03). No adverse events were recorded in the tannin group, while two placebo patients reported diarrhea and abdominal pain.

4
Chestnut Inner Skin Extract With Boiled Rice: Blood Sugar Rise in Rats and People
PubMed

Laboratory enzyme tests, rat starch-loading tests and a human boiled-rice test of an ethanol extract of chestnut astringent (inner) skin; the abstract gives no human group size, control design, chestnut species or funding details (Tsujita et al. 2008, J Nutr Sci Vitaminol (Tokyo))

Normal rats and a type 2 diabetic rat model; human volunteers (number not stated in the abstract).

The extract strongly inhibited human and pig pancreatic alpha-amylase and suppressed the blood sugar and insulin rise after starch in rats in a dose-dependent way. In people, 300 and 600 mg of extract reduced the rise in plasma glucose after boiled rice by 11 and 23 percent. Only the abstract was available for this summary.

5
Quebracho and Chestnut Tannin Blend for 60 Days: Uncontrolled Pilot
PubMed

Prospective single-arm, open-label before-after pilot; capsules with 240 mg of a standardized quebracho wood and chestnut tannin blend from Silvateam plus 0.72 micrograms of vitamin B12, twice daily (480 mg a day of the blend) for 60 days; registered NCT05207618; sponsored by Hospital de Clinicas Jose de San Martin, with the product supplied by Silvateam, which employs the first author (Molino et al. 2026, Mol Nutr Food Res)

31 adults with diarrhea-predominant irritable bowel syndrome enrolled; 28 completed.

The symptom score fell by an estimated 70 points from baseline, stool consistency improved and daily bowel movements fell; serum zonulin fell, stool butyrate rose and propionate fell. No adverse events occurred. With no placebo group, these before-after changes cannot be attributed to the blend.

Side effects and drug interactions

Common Potential side effects

Allergy: chestnut can cause allergic reactions, including oral allergy syndrome, which in one reported case also brought on nose, eye and asthma symptoms. Many reported cases occur in people with latex allergy, and a lipid transfer protein, Cas s 8, was a major allergen in people allergic to chestnut but not latex. In Korea, 3.2 percent of 1,738 patients with respiratory allergies had a positive chestnut skin test.
Labeling: under FDA's January 2025 allergen guidance, chestnut is not one of the 12 tree nuts treated as major food allergens, so it should not appear in a Contains statement, although it must still be named in the ingredient list. People who have reacted to chestnut should read ingredient lists.
Horse chestnut mix-ups: raw horse chestnut seeds look like sweet chestnuts but are unsafe to eat (NCCIH). A man who ate horse chestnut seeds he took for Korean chestnuts developed stomach pain, nausea and a brief irregular heart rhythm.
Tannin blends: no side effects were reported in a 56 day trial of a quebracho and chestnut blend, and no adverse events were recorded in the tannin group of a 14 day trial. These trials were short, so longer-term safety of chestnut tannin extracts is not known.
Carbohydrate: roasted chestnuts supply 53.0 g of carbohydrate and 245 kcal per 100 g (USDA), which counts toward daily carbohydrate for anyone tracking blood sugar.

Important Drug interactions

No formal drug interaction studies of chestnuts or chestnut tannin extracts were found among the sources reviewed for this page.
Diabetes medicines: chestnuts are a carbohydrate food, and chestnut flour bread and a chestnut skin extract changed the blood sugar response to a meal in short tests. Monitor readings if chestnut products become a regular part of the diet, and do not change a prescription on your own.
Prescribed treatment: in a hospital trial the tannin blend was given alongside standard care and did not change clinical outcomes, so tannin supplements should not replace prescribed treatment.

Frequently asked questions about Chestnut (Sweet Chestnut, Castanea sativa)

Is sweet chestnut the same as horse chestnut?

No. Sweet chestnuts are the edible nuts of Castanea trees. Horse chestnut (Aesculus hippocastanum) is a different tree whose seeds look similar but taste bitter, and NCCIH says its raw seeds, bark, flowers and leaves are unsafe to take by mouth. Horse chestnut seed extracts sold for leg vein comfort are separate products from chestnut foods and chestnut tannin extracts.

Are chestnuts a major food allergen on US labels?

No. FDA's January 2025 allergen guidance lists 12 tree nuts as major food allergens, including almond, cashew, hazelnut, pecan, pine nut, pistachio and walnuts, and chestnut is not among them. Chestnut should not appear in a Contains statement but must still be named in the ingredient list. Chestnut allergy does occur, often together with latex allergy, so anyone who has reacted should avoid it.

Can chestnut packages use FDA's qualified health claim for nuts?

No. In 2003 FDA said it would consider enforcement discretion for a qualified claim that eating 1.5 ounces a day of most nuts, as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. The petition named peanuts and nine tree nuts, and chestnuts were not among them; the letter does not mention chestnuts. It is a qualified claim, not an FDA-authorized health claim.

How are chestnuts different from other nuts?

Chestnuts are mostly carbohydrate and water. Per 100 g roasted, USDA lists 245 kcal, 53.0 g of carbohydrate and 2.2 g of fat, while English walnuts have 654 kcal and 65.2 g of fat. A 28 g serving of roasted chestnuts supplies about 70 kcal. Chestnut flour is used in breads and baking, where it replaces part of the wheat flour.

What chestnut supplements have been studied in people?

Only blends. The human trials tested quebracho wood and chestnut tannin extracts together, at 480 mg a day for up to 60 days, so their results cannot be credited to chestnut alone. A human test of a chestnut inner skin extract with rice is reported only briefly in an abstract. No trial has tested whole chestnuts over weeks.

What is Chestnut?

Sweet chestnuts are the edible nuts of Castanea trees, mainly the European Castanea sativa and related Asian and American species, eaten roasted or boiled or as chestnut flour. Unlike most tree nuts they are low in fat and high in carbohydrate: USDA lists 245 kcal, 2.2 g of fat and 53.

What is Chestnut used for?

NutraSmarts does not list Chestnut under a health category. What the research covers: In a randomized crossover test in 14 healthy adults, bread made with 50 percent chestnut flour, eaten as a meal with 50 g of carbohydrate, gave a 27 percent smaller blood sugar rise over 3 hours than wheat bread, mostly at 2 to 2.5 hours.

What is the recommended dosage of Chestnut?

The clinically studied dose is Chestnut flour: bread made with 50 percent chestnut flour in one meal with 50 g of carbohydrate. Quebracho and chestnut tannin blends: 480 mg a day for 56 to 60 days, or two 240 mg capsules a day for 14 days. No supplement dose is established. Always follow the product label and check with a healthcare provider for personal advice.

Is Chestnut safe, and does it have side effects?

Side effects and cautions reported for Chestnut include: Allergy: chestnut can cause allergic reactions, including oral allergy syndrome, which in one reported case also brought on nose, eye and asthma symptoms. It may also interact with some medications. Chestnut is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Chestnut interact with any medications?

Possible interactions include: No formal drug interaction studies of chestnuts or chestnut tannin extracts were found among the sources reviewed for this page. Diabetes medicines: chestnuts are a carbohydrate food, and chestnut flour bread and a chestnut skin extract changed the blood sugar response to a meal… If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Chestnut?

NutraSmarts rates the evidence for Chestnut as Limited (2 out of 5). It is backed by 5 study summaries and 15 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(15 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Houghton MJ, Peiris DR, Sulaimani N, Visvanathan R, Nicolotti L, Cardoso BR. Chestnut flour-enriched bread reduces postprandial glycaemic response in healthy adults: a randomised, controlled crossover study. Food Funct. 2026;17(19):8795-8807. doi: 10.1039/d6fo02120d.PubMedUsed to support: Randomized crossover single-meal trial in 14 healthy adults: isocaloric meals with 50 g of available carbohydrate as bread made with 50 percent chestnut flour and 50 percent wheat flour, or 100 percent wheat bread, after an overnight fast. Glucose incremental area under the curve over 180 minutes was 27 percent lower with the chestnut flour bread (p = 0.0319), with glucose 16 percent lower at 120 minutes and 14 percent lower at 150 minutes. Total insulin exposure did not differ, and the insulin peak came about 24 minutes earlier. The chestnut bread held about 480 mg of total polyphenols (including catechin, myricetin and gallic acid) against about 100 mg in the control bread. The abstract states no funding source or registration; a Monash University registry entry by the senior author (NCT06960967, read on ClinicalTrials.gov) lists postprandial glucose and insulin iAUC as primary outcomes.
  2. Molino S, De Lellis LF, Morone MV, Cordara M, Larsen DS, Piccinocchi R, Piccinocchi G, Baldi A, Di Minno A, El-Seedi HR, Sacchi R, Daglia M. Improving Irritable Bowel Syndrome (IBS) Symptoms and Quality of Life with Quebracho and Chestnut Tannin-Based Supplementation: A Single-Centre, Randomised, Double-Blind, Placebo-Controlled Clinical Trial. Nutrients. 2025;17(3):552. doi: 10.3390/nu17030552.PubMedUsed to support: Single-center randomized, double-blind, placebo-controlled trial in 156 adults with irritable bowel syndrome (Rome IV), 78 per group: two 240 mg capsules a day of Welltan Complex, a blend of quebracho (Schinopsis lorentzii) wood and chestnut (Castanea sativa) tannin extracts, for 56 days (the cited registry title describes the chestnut component as bark). Primary outcome, the IBS Severity Scoring System: 148.1 on the blend versus 247.4 on placebo at 56 days (model difference 98.2 points, p < 0.001); the blend group started higher (242.3 versus 217.3) and placebo scores rose. Quality of life scores favored the blend but differed sharply at baseline; Bristol stool consistency did not differ by treatment. No side effects were reported. The paper states no external funding; product and placebo were supplied free by the INBB consortium as trial sponsor, Silvateam is thanked for the samples, and the first author is a Silvateam employee. The abstract labels the change as going from mild to moderate, the reverse of the scale defined in the methods.
  3. Molino S, Pisarevsky A, Badu S, Wu Q, Mingorance FL, Vega P, Stefanolo JP, Repetti J, Ludueña G, Pepa P, Olmos JI, Fermepin MR, Uehara T, Viciani E, Castagnetti A, Savidge T, Piskorz MM. Randomized placebo-controlled trial of oral tannin supplementation on COVID-19 symptoms, gut dysbiosis and cytokine response. J Funct Foods. 2022;99:105356. doi: 10.1016/j.jff.2022.105356.PubMedUsed to support: Randomized, double-blind, placebo-controlled trial in 124 adults hospitalized with non-life-threatening COVID-19 in Buenos Aires: Arbox Microbiota (Indunor S.A.), two capsules a day each with 240 mg of a quebracho and chestnut tannin extract blend and 0.72 micrograms of vitamin B12, or placebo, for 14 days added to standard care (registered NCT04403646). The primary outcome, time to hospital discharge within 28 days, and secondary outcomes (28-day mortality, invasive ventilation) did not differ, and the gut microbiome did not shift significantly. MIP-1 alpha fell with the tannin blend (p = 0.03). No adverse events were recorded in the tannin group; two placebo patients reported diarrhea and abdominal pain. Supported in part by Silvateam/Indunor SA and by NIH grants.
  4. Molino S, Pisarevsky A, Mingorance FL, Vega P, Stefanolo JP, Repetti J, Ludueña G, Pepa P, Olmos JI, Fermepin MR, Uehara T, Villapol S, Savidge T, Treangen T, Viciani E, Castagnetti A, Piskorz MM. Natural tannin extracts supplementation for COVID-19 patients (TanCOVID): a structured summary of a study protocol for a randomized controlled trial. Trials. 2021;22(1):310. doi: 10.1186/s13063-021-05281-x.PubMedUsed to support: Published protocol of the TanCOVID trial: a double-blind, randomized, placebo-controlled parallel trial of ARBOX, described as a blend of quebracho and chestnut tannin extracts with vitamin B12, two capsules a day for 14 days in hospitalized adults with COVID-19, with time to hospital discharge as the primary outcome and a planned 140 patients (NCT04403646). Pregnant and breastfeeding patients and people hypersensitive to polyphenols were excluded.
  5. Molino S, Piskorz MM, Lerma-Aguilera A, Mingorance FL, Gutierrez C, Montero JM, Uehara T, Hashimoto H, Ballerga EG, Olmos JA. Tannin Phytocomplex Improves IBS-D Symptoms and Gut-Brain Markers: Prospective Pilot Study. Mol Nutr Food Res. 2026;70(8):e70451. doi: 10.1002/mnfr.70451.PubMedUsed to support: Prospective single-arm, open-label before-after pilot (NCT05207618): 31 adults with diarrhea-predominant irritable bowel syndrome enrolled and 28 completed 60 days of 480 mg a day of a standardized blend of quebracho wood and chestnut (Castanea sativa) tannin extracts from Silvateam, given as two capsules each with 240 mg of the blend plus 0.72 micrograms of vitamin B12. The symptom score fell by an estimated 70 points from baseline, stool consistency improved, bowel movements per day fell, serum zonulin fell, stool butyrate rose and propionate fell, and no adverse events occurred. There was no placebo group. Sponsored by Hospital de Clinicas Jose de San Martin; Silvateam supplied the product and employed the first author.
  6. Tsujita T, Takaku T, Suzuki T. Chestnut astringent skin extract, an alpha-amylase inhibitor, retards carbohydrate absorption in rats and humans. J Nutr Sci Vitaminol (Tokyo). 2008;54(1):82-8. doi: 10.3177/jnsv.54.82.PubMedUsed to support: Laboratory, rat and human study of an ethanol extract of chestnut astringent (inner) skin: the extract strongly inhibited human and pig pancreatic alpha-amylase, and in normal and diabetic model rats it suppressed the blood sugar rise after starch in a dose-dependent way, along with the insulin rise. In people eating boiled rice, 300 and 600 mg of extract reduced the rise in plasma glucose by 11 and 23 percent. The abstract does not give the number of human volunteers, the control design or the chestnut species.
  7. Sánchez-Monge R, Blanco C, López-Torrejón G, Cumplido J, Recas M, Figueroa J, Carrillo T, Salcedo G. Differential allergen sensitization patterns in chestnut allergy with or without associated latex-fruit syndrome. J Allergy Clin Immunol. 2006;118(3):705-10. doi: 10.1016/j.jaci.2006.04.058.PubMedUsed to support: Allergen study in 12 people sensitized to chestnut but not latex and 3 with latex and chestnut allergy: a 9 kDa lipid transfer protein, Cas s 8, was a major chestnut allergen in those without latex allergy (IgE in 91 percent by immunoblotting and 58 percent by ELISA), while people with latex-chestnut allergy reacted instead to class I chitinase and latex hevein. The authors note chestnut allergy has mostly been studied as part of the latex-fruit syndrome.
  8. Lee SK, Yoon SH, Kim SH, Choi JH, Park HS. Chestnut as a food allergen: identification of major allergens. J Korean Med Sci. 2005;20(4):573-8. doi: 10.3346/jkms.2005.20.4.573.PubMedUsed to support: Skin prick testing in 1,738 Korean patients with respiratory allergies: 56 (3.2 percent) showed a positive chestnut reaction. Twenty-one IgE-binding chestnut proteins were found, including a new 24 kDa allergen, and simulated digestion and boiling reduced IgE binding in the laboratory.
  9. Antico A. Oral allergy syndrome induced by chestnut (Castanea sativa). Ann Allergy Asthma Immunol. 1996;76(1):37-40. doi: 10.1016/S1081-1206(10)63404-7.PubMedUsed to support: Case report of oral allergy syndrome to fresh chestnut (Castanea sativa), confirmed by food challenge, in a patient with dust mite respiratory allergy, which the author calls unusual because the few earlier cases involved latex-sensitive patients; the challenge also brought on rhinoconjunctivitis and asthma symptoms. Commercial skin test extracts and blood IgE tests were negative, while a skin test with freshly prepared chestnut extract was positive.
  10. Yi HY, Lee JY. Poisoning due to consumption of horse chestnut seed. Clin Exp Emerg Med. 2021;8(4):333-335. doi: 10.15441/ceem.20.004.PubMedUsed to support: Case report: a 46-year-old man ate horse chestnut (Aesculus hippocastanum) seeds he mistook for edible Korean chestnuts (Castanea crenata) and came to the emergency department with stomach pain, nausea and sweating, slightly raised liver enzymes and amylase, and a period of atrial fibrillation that had resolved by the next day. The authors note the two fruits look very similar.
  11. U.S. Department of Agriculture, Agricultural Research Service. FoodData Central: Nuts, chestnuts, european, roasted (SR Legacy, FDC ID 170190). USDA FoodData Central. 2019;SR Legacy food 12167..SourceUsed to support: Not PubMed-indexed; USDA nutrient database entry read via the FoodData Central site data (last updated April 2019). Per 100 g of roasted European chestnuts: 245 kcal, 40.5 g water, 3.17 g protein, 2.2 g fat (0.414 g saturated, 0.759 g monounsaturated, 0.869 g polyunsaturated), 53.0 g carbohydrate, 5.1 g fiber, 10.6 g total sugars, 592 mg potassium, 0.507 mg copper, 1.18 mg manganese, 26.0 mg vitamin C, 0.497 mg vitamin B6 and 70 micrograms folate; 1 oz is 28.35 g and 1 cup is 143 g. The entry gives no starch value.
  12. U.S. Department of Agriculture, Agricultural Research Service. FoodData Central: Nuts, walnuts, english (SR Legacy, FDC ID 170187). USDA FoodData Central. 2019;SR Legacy food 12155..SourceUsed to support: Not PubMed-indexed; USDA nutrient database entry read via the FoodData Central site data (last updated April 2019), used here for comparison. Per 100 g of English walnuts: 654 kcal, 65.2 g fat, 13.7 g carbohydrate, 15.2 g protein and 6.7 g fiber.
  13. U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition (Taylor CL). Qualified Health Claims: Letter of Enforcement Discretion - Nuts and Coronary Heart Disease (Docket No 02P-0505). U.S. Food and Drug Administration. 2003;Letter dated July 14, 2003, to the International Tree Nut Council Nutrition Research and Education Foundation; archived FDA page linked from FDA's current list of qualified health claim letters, read 2026..SourceUsed to support: Not PubMed-indexed; archived FDA letter read. The petition identified peanuts and nine tree nuts (almonds, Brazil nuts, cashew nuts, hazelnuts, macadamia nuts, pecans, pine nuts, pistachio nuts and walnuts); chestnuts are not mentioned anywhere in the letter, and seeds are not mentioned. FDA found no significant scientific agreement for an authorized claim but will consider enforcement discretion for the qualified claim "Scientific evidence suggests but does not prove that eating 1.5 ounces per day of most nuts [, such as name of specific nut,] as part of a diet low in saturated fat and cholesterol may reduce the risk of heart disease." It excluded Brazil nuts, macadamia nuts, cashew nuts and some varieties of pine nuts as above the saturated fat disqualifying levels, and nut-containing products need at least 11 g of the nuts cited in the petition per reference amount customarily consumed.
  14. U.S. Food and Drug Administration, Human Foods Program. Questions and Answers Regarding Food Allergens, Including the Food Allergen Labeling Requirements of the Federal Food, Drug, and Cosmetic Act (Edition 5): Guidance for Industry. U.S. Food and Drug Administration. 2025;Final guidance, January 2025; docket FDA-2022-D-0099; PDF read 2026..SourceUsed to support: Not PubMed-indexed; FDA guidance read. Major food allergens are milk, eggs, fish, Crustacean shellfish, tree nuts, peanuts, wheat, soybeans and sesame (added by the FASTER Act of 2021). Table 1 lists the 12 tree nuts FDA considers major food allergens: almond, black walnut, Brazil nut, California walnut, cashew, filbert/hazelnut, heartnut/Japanese walnut, macadamia nut/bush nut, pecan, pine nut/pinon nut, pistachio and English/Persian walnut. Chestnut is not listed. Tree nuts not in Table 1 should not be included in the Contains statement but must still be listed by common or usual name in the ingredient list.
  15. National Center for Complementary and Integrative Health. Horse Chestnut. National Institutes of Health. 2025;Web fact sheet, last updated April 2025; read 2026..SourceUsed to support: Not PubMed-indexed; NIH fact sheet read. Horse chestnut (Aesculus hippocastanum) fruits contain seeds that resemble sweet chestnuts but have a bitter taste. The raw seeds, bark, flowers and leaves are unsafe when used orally because they contain a toxic component; standardized seed extracts with this component removed are likely safe for short-term use.